To prevent COVID pre-exposure prophylaxis in immunocompromised adolescents, Pemivibart is administered EUA.

Published Date: 28 Mar 2024

Pemivibart is first given as a single intravenous infusion at a dose of 4500 mg. According to the FDA, if continued protection is required, a repeat dose of 4500 mg should be given every three months.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

2.

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

3.

Research finds stark disparities in treatment and survival time for people with pancreatic cancer

4.

Tumor characteristics found to differ for melanomas in children, teens and young adults

5.

Relationship-building key to addressing oncologist shortages in rural care


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot